Efficacy And Safety Of Bortezomib-Rituximab (Vcr) Vs Rituximab (R) In Patients (Pts) With Relapsed, R-Naive/-Sensitive Follicular Lymphoma (Fl): Outcome According To Prior Therapy
AuthID
P-002-R38
P-002-R38